Mastectomy Reconstruction Outcomes Consortium (MROC) Study

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT01723423
Collaborator
Memorial Sloan Kettering Cancer Center (Other), M.D. Anderson Cancer Center (Other), Northwestern Memorial Hospital (Other), Georgetown University (Other), Ohio State University (Other), Saint Joseph Mercy Health System (Other), Georgia Institute for Plastic Surgery (Other), Brigham and Women's Hospital (Other), University of Manitoba (Other), Providence Health & Services (Other)
4,436
11
64
403.3
6.3

Study Details

Study Description

Brief Summary

The MROC Study seeks to evaluate and compare from the patient's point of view the leading options for breast reconstruction after mastectomy. This study will help patients, physicians, payers and policy makers better understand the various surgeries available for breast reconstruction. Although many women choose reconstruction, the number of options as well as their pros and cons can make decision making difficult and stressful. From this research, we hope to learn more about what works best for patients undergoing these operations.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Despite the growing use of breast conservation as primary therapy for breast cancer, mastectomy remains a common treatment option. Many patients choose to undergo breast reconstruction as an effective means of lessening the adverse impact of mastectomy on psychosocial functioning and quality of life. Despite these benefits, well-designed studies comparing the current choices from the patient's point of view are difficult (if not impossible) to come by. Previous research on breast reconstruction outcomes has also failed to include race and ethnicity as key variables. In order to actively participate in the reconstruction decision making process, breast cancer survivors need objective, up-to-date information on breast reconstruction outcomes from the patient's perspective.

    The proposed Mastectomy Reconstruction Outcomes Consortium (MROC) Study will use a prospective cohort design to compare outcomes for the eight commonly used options for breast reconstruction: expander/implant, latissimus dorsi/implant (LD), pedicle transverse rectus abdominis musculocutaneous (PTRAM), free TRAM (FTRAM), deep inferior epigastric perforator (DIEP), superficial inferior epigastric artery (SIEA), superior gluteal artery perforator (SGAP) and inferior gluteal artery perforator (IGAP) techniques.

    Outcomes assessed will include complications, postoperative pain, psychosocial well-being, physical functioning, fatigue, patient satisfaction and costs. The project will also evaluate the effects of race and ethnicity on reconstruction outcomes. Thirteen leading centers in the United States and Canada will participate. Together, these institutions perform over 3000 breast reconstructions annually. The five year study will evaluate patients preoperatively and at one week, three months, one year and two years following reconstruction. For data sources, the project will rely on medical and billing records, as well as a panel of generic and condition-specific patient-report outcome measures.

    The MROC Study will benefit a variety of stakeholders in the healthcare marketplace: The project will provide consumers, providers, payers, and policy-makers with reliable, up-to-date information on the effectiveness and relative costs of surgical options for breast reconstruction, thereby promoting a more evidence-based approach to treatment and policy decision-making. Study findings will also assist health care organizations in designing systems of care tailored to the specific needs and preferences of diverse patient populations.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    4436 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Mastectomy Reconstruction Outcomes Consortium (MROC) Study
    Study Start Date :
    Aug 1, 2011
    Actual Primary Completion Date :
    Dec 1, 2016
    Actual Study Completion Date :
    Dec 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Expander/Implant

    Patients receiving expander/implant breast reconstruction procedures.

    Lat Dorsi

    Patients receiving latissimus dorsi breast reconstructions with or without implant.

    PTRAM

    Patients receiving pedicle transverse rectus abdominis musculocutaneous (PTRAM)breast reconstruction.

    FTRAM

    Patients receiving free transverse rectus abdominis musculocutaneous (FTRAM.)

    DIEP

    Patients receiving deep inferior epigastric perforator (DIEP) breast reconstructions.

    SIEA

    Patients receiving superficial inferior epigastric artery (SIEA)breast reconstruction.

    S-GAP

    Patients receiving superior gluteal artery perforator breast reconstruction.

    I-GAP

    Patients receiving inferior gluteal artery perforator breast reconstruction.

    Outcome Measures

    Primary Outcome Measures

    1. Change from baseline in health-related quality of life. [Change from baseline at 1 week, 3 months, 1 year and 2 years post-operatively.]

      Patient reported outcome measures will include patient satisfaction, post-operative pain, body image, psycho-social functioning, physical functioning, and fatigue.

    Secondary Outcome Measures

    1. The effects of race and ethnicity on reconstruction outcomes. [Pre-operatively and at 1 week, 3 months, 1 year and 2 years postoperatively]

      Although the study will not be adequately powered to analyze outcomes by procedure type within racial and ethnic categories, we will obtain descriptive statistics for the effects of race and ethnicity on breast reconstruction outcomes.

    2. Descriptive statistics on the relative costs of the eight procedure types. [2 years postoperatively]

      Obtain descriptive statistics on the costs of each of the seven procedure types, to gain a better understanding of the cost differences between procedures.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women who present themselves for reconstruction at one of 11 MROC centers

    • Women undergoing one of the following types of breast reconstruction after mastectomy: tissue expander/implant, LD flap (with, or without implant), PTRAM flap, FTRAM flap, DIEP flap, S-GAP flap, I-GAP flap or SIEA flap.

    • Immediate or delayed reconstruction

    • Unilateral or bilateral reconstructions.

    • Women receiving mastectomy for cancer prophylaxis, without history of breast cancer, will be eligible to participate.

    Exclusion Criteria:
    • Patients electing reconstruction following complications of breast augmentation, mastopexy (breast lift), or breast reduction will not be recruited for the study.

    • Procedures performed following previously failed attempts at breast reconstruction will be excluded from the study, due to potential confounding by these previous surgeries.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Georgetown University Hospital Washington, D.C. District of Columbia United States 20007
    2 Georgia Institute for Plastic Surgery Savannah Georgia United States 31405
    3 Northwestern Memorial Hospital Chicago Illinois United States 60611-2923
    4 Brigham and Women's Hospital Boston Massachusetts United States 02115
    5 University of Michigan Medical Center Ann Arbor Michigan United States 48109
    6 St. Joseph's Mercy Health System Ann Arbor Michigan United States 48197
    7 Memorial Sloan-Kettering Cancer Center New York New York United States 10065
    8 Ohio State University Medical Center Columbus Ohio United States 43212-3154
    9 M.D. Anderson Cancer Center Houston Texas United States 77030
    10 Providence Health Care - University of British Columbia Vancouver British Columbia Canada
    11 University of Manitoba Winnipeg Manitoba Canada R3A 1R9

    Sponsors and Collaborators

    • University of Michigan
    • Memorial Sloan Kettering Cancer Center
    • M.D. Anderson Cancer Center
    • Northwestern Memorial Hospital
    • Georgetown University
    • Ohio State University
    • Saint Joseph Mercy Health System
    • Georgia Institute for Plastic Surgery
    • Brigham and Women's Hospital
    • University of Manitoba
    • Providence Health & Services

    Investigators

    • Principal Investigator: Edwin G Wilkins, MD, MS, University of Michigan
    • Principal Investigator: Andrea L. Pusic, MD, MHSA, Memorial Sloan Kettering Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Edwin G. Wilkins, Professor of Surgery, University of Michigan
    ClinicalTrials.gov Identifier:
    NCT01723423
    Other Study ID Numbers:
    • 10-PAF07150
    First Posted:
    Nov 7, 2012
    Last Update Posted:
    Jul 13, 2017
    Last Verified:
    Mar 1, 2017
    Keywords provided by Edwin G. Wilkins, Professor of Surgery, University of Michigan
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 13, 2017